The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Donenberg Phillip B. | Director | Grant(A) | 13K | — | $0 |
| Jun 10, 2026 | Holmen Bob | Director | Grant(A) | 13K | — | $0 |
| Jun 10, 2026 | Gerry Christopher | President & PEO | Grant(A) | 220K | — | $0 |
| Jun 1, 2026 | Cambrian BioPharma Inc | 10% Owner | Sell(S) | 25K | $20.00 | $490K |
| Jun 1, 2026 | Cambrian BioPharma Inc | 10% Owner | Sell(S) | 476 | $21.14 | $10K |
| Jun 1, 2026 | Peyer James | 10% Owner | Sell(S) | 25K | $20.00 | $490K |
| Jun 1, 2026 | Peyer James | 10% Owner | Sell(S) | 476 | $21.14 | $10K |
| Apr 10, 2026 | Donenberg Phillip B. | Director | Grant(A) | 23K | — | $0 |
| Apr 10, 2026 | Craver Josiah | PFO & PAO | Grant(A) | 80K | — | $0 |
| Apr 7, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 1K | $33.38 | $37K |
| Apr 7, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 2K | $28.94 | $61K |
| Apr 7, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 205 | $29.71 | $6K |
| Apr 7, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 4K | $31.38 | $139K |
| Apr 7, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 300 | $32.25 | $10K |
| Apr 7, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 1K | $33.38 | $37K |
| Apr 6, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 1K | $31.02 | $34K |
| Apr 6, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 1K | $31.02 | $38K |
| Apr 6, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 45 | $31.96 | $1K |
| Apr 2, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 26 | $33.47 | $870 |
| Apr 2, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 1K | $34.75 | $44K |
| Apr 2, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 701 | $35.55 | $25K |
| Apr 2, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 3K | $30.86 | $96K |
| Apr 2, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 1K | $31.75 | $40K |
| Apr 2, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 2K | $32.60 | $58K |
| Apr 2, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 374 | $33.35 | $12K |
| Apr 2, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 1K | $34.80 | $39K |
| Apr 1, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 1K | $31.53 | $37K |
| Apr 1, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 2K | $34.59 | $56K |
| Apr 1, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 3K | $35.46 | $121K |
| Apr 1, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 1K | $31.52 | $35K |
| Apr 1, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 46 | $34.75 | $2K |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 616 | $24.69 | $15K |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 2K | $25.32 | $45K |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 1K | $26.73 | $28K |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 17 | $27.78 | $472 |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 186 | $30.48 | $6K |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 2K | $31.45 | $62K |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 411 | $32.60 | $13K |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 191 | $24.28 | $5K |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 1K | $25.17 | $31K |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 57 | $27.11 | $2K |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 5 | $28.41 | $142 |
| Mar 31, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 87 | $31.52 | $3K |
| Mar 30, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 3K | $25.08 | $75K |
| Mar 30, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 5K | $25.99 | $130K |
| Mar 30, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 1K | $26.70 | $31K |
| Mar 30, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 370 | $27.68 | $10K |
| Mar 30, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 518 | $25.85 | $13K |
| Mar 30, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 370 | $27.68 | $10K |
| Mar 27, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 11K | $26.29 | $280K |
| Mar 27, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 4K | $27.28 | $120K |
| Mar 27, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 294 | $28.13 | $8K |
| Mar 27, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 469 | $26.77 | $13K |
| Mar 27, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 36 | $27.37 | $985 |
| Mar 26, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 778 | $27.23 | $21K |
| Mar 26, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 1K | $27.95 | $37K |
| Mar 26, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 3K | $28.85 | $75K |
| Mar 26, 2026 | Millennium Management LLC | 10% Owner | Buy(P) | 1K | $29.98 | $31K |
| Mar 26, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 583 | $26.88 | $16K |
| Mar 26, 2026 | Millennium Management LLC | 10% Owner | Sell(S) | 1K | $28.69 | $37K |
| Feb 13, 2026 | Donenberg Phillip B. | Director | Grant(A) | 2K | — | $0 |
| Dec 9, 2025 | Peyer James | 10% Owner | Sell(S) | 395 | $8.04 | $3K |
| Dec 9, 2025 | Peyer James | 10% Owner | Sell(S) | 3K | $7.95 | $21K |
| Dec 9, 2025 | Peyer James | 10% Owner | Sell(S) | 446 | $7.92 | $4K |
| Dec 9, 2025 | Peyer James | 10% Owner | Option exercise(M) | 395 | $6.40 | $3K |
| Dec 9, 2025 | Peyer James | 10% Owner | Option exercise(M) | 395 | — | $0 |
| Dec 9, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell(S) | 3K | $8.59 | $27K |
| Dec 9, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell(S) | 446 | $7.92 | $4K |
| Dec 9, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell(S) | 395 | $8.04 | $3K |
| Dec 9, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell(S) | 3K | $7.95 | $21K |
| Dec 9, 2025 | Cambrian BioPharma Inc | 10% Owner | Option exercise(M) | 395 | $6.40 | $3K |
| Dec 9, 2025 | Cambrian BioPharma Inc | 10% Owner | Option exercise(M) | 395 | — | $0 |
| Dec 8, 2025 | Peyer James | 10% Owner | Sell(S) | 3K | $8.59 | $27K |
| Dec 5, 2025 | Peyer James | 10% Owner | Sell(S) | 15K | $11.40 | $165K |
| Dec 5, 2025 | Peyer James | 10% Owner | Sell(S) | 42 | $13.16 | $553 |
| Dec 5, 2025 | Peyer James | 10% Owner | Sell(S) | 2K | $12.29 | $21K |
| Dec 5, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell(S) | 15K | $11.40 | $165K |
| Dec 5, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell(S) | 42 | $13.16 | $553 |
| Dec 5, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell(S) | 2K | $12.29 | $21K |
| Dec 4, 2025 | Peyer James | 10% Owner | Sell(S) | 5K | $9.06 | $45K |
| Dec 4, 2025 | Cambrian BioPharma Inc | 10% Owner | Sell(S) | 5K | $9.06 | $45K |
| May 21, 2025 | Ringo William R | Director | Grant(A) | 19K | — | $0 |
| May 21, 2025 | Holmen Bob | Director | Grant(A) | 19K | — | $0 |
| May 21, 2025 | Humer Kristian | Director | Grant(A) | 19K | — | $0 |
| May 21, 2025 | Peyer James | Director, 10% Owner | Grant(A) | 19K | — | $0 |
| May 21, 2025 | Ricks Thomas G | Director | Grant(A) | 19K | — | $0 |
| May 21, 2025 | Cambrian BioPharma Inc | 10% Owner | Grant(A) | 19K | — | $0 |
| Feb 19, 2025 | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | Tax withholding(F) | 2K | $0.48 | $1K |
| Feb 19, 2025 | Celebi John | PRESIDENT AND CEO, Director | Tax withholding(F) | 6K | $0.48 | $3K |
| Feb 14, 2025 | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | Grant(A) | 110K | — | $0 |
| Feb 14, 2025 | Celebi John | PRESIDENT AND CEO, Director | Grant(A) | 360K | — | $0 |
| Feb 14, 2025 | Craver Josiah | Principal Financial Officer | Grant(A) | 50K | — | $0 |
| Feb 14, 2025 | Krebs Stephanie | Chief Business Officer | Grant(A) | 120K | — | $0 |
| Dec 20, 2024 | Celebi John | PRESIDENT AND CEO, Director | Grant(A) | 355K | — | $0 |
| Dec 20, 2024 | Craver Josiah | Principal Financial Officer | Grant(A) | 100K | — | $0 |
| Dec 20, 2024 | van der Horst Edward | CHIEF SCIENTIFIC OFFICER | Grant(A) | 100K | — | $0 |
| Dec 20, 2024 | Krebs Stephanie | Chief Business Officer | Grant(A) | 120K | — | $0 |
| Jun 11, 2024 | Vojta Deneen | Director | Grant(A) | 19K | — | $0 |
| Jun 11, 2024 | Ricks Thomas G | Director | Grant(A) | 19K | — | $0 |
| Jun 11, 2024 | Ringo William R | Director | Grant(A) | 19K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2019-12-30 → 2026-08-06. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SNSE